Study of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema

Similar documents
COMPARISON OF INTRAVITREAL TRIAMCINOLONE INJECTION VS LASER PHOTOCOAGULATION IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETIC RETINOPATHY

ROLE OF LASER PHOTOCOAGULATION VERSUS INTRAVITREAL TRIAMCINOLONE ACETONIDE IN ANGIOGRAPHIC MACULAR EDEMA IN DIABETES MELLITUS

OCT Assessment of the Vitreoretinal Relationship in CSME

Optical coherence tomography in diabetic macular edema: patterns and related risk factors

Clinically Significant Macular Edema (CSME)

Recalcitrant Diabetic Macular Oedema: Therapeutic Options

Role of OCT in the diagnosis and follow up of diabetic macular edema

biomicroscopy and stereoscopic photography are subjective and insensitive to small changes in retinal thickness ] 5[ Measurement of the integrity of t

New Developments in the treatment of Diabetic Retinopathy

Is OCT-A Needed As An Investigative Tool During The Management Of Diabetic Macular Edema

The Human Eye. Cornea Iris. Pupil. Lens. Retina

To Study the correlation between fundus fluorescein angiography and optical coherence tomography patterns in clinically significant macular oedema

OCT in Diabetic Macular Edema and its Correlation with Flourescein Angiography

Andrew J. Barkmeier, MD; Benjamin P. Nicholson, MA; Levent Akduman, MD

VISUAL OUTCOME IN DIABETIC MACULAR EDEMA AFTER GRID LASER TREATMENT

Optical Coherence Tomograpic Features in Idiopathic Retinitis, Vasculitis, Aneurysms and Neuroretinitis (IRVAN)

Diabetic Retinopathy. Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012

A retrospective nonrandomized study was conducted at 3

Case Report Inherent Challenges in Managing Long Standing Refractory Diabetic Macular Edema

EPIRETINAL MEMBRANE & VITREOMACULAR TRACTION

Diabetic Retinopathy


Vitrectomy for Diabetic Cystoid Macular Edema

Jay M. Haynie, O.D.; F.A.A.O. Olympia Tacoma Renton Kennewick Washington

PART 1: GENERAL RETINAL ANATOMY

Intravitreal Monotherapy with Bevacizumab and Triamcinolone Versus Combination Therapy in Recalcitiant Diabetic Macular Edema

Published on Points de Vue International Review of Ophthalmic Optics (

Ophthalmology Macular Pathways

Scott M. Pfahler D.O. Dayton Vitreo-Retinal Associates AOCOO-HNS Palm Springs, CA 2012

ORIGINAL ARTICLE. Introduction. June 2009 Kerala Journal of Ophthalmology 139

Visual and Anatomical Outcomes of Vitreous Surgery for Large Macular Holes

Clinical Trials in Diabetic Retinopathy. Harry W. Flynn Jr., M.D. Nidhi Relhan Batra, M.D.

Diabetic Retinopathy A Presentation for the Public

Moncef Khairallah, MD

THE ROLE OF anti-vegf IN DIABETIC RETINOPATHY AND AGE RELATED MACULAR DEGENERATION

Diabetic eye disease. Diabetic retinopathy. Sam S. Dahr, M.D. Retina Center of Oklahoma.

3/6/2014. Hoda MH Mostafa MD Associate Professor of Ophthalmology Cairo University. The author has no proprietary interest. Today s Objectives

Clinical Outcomes After Intravitreal Bevacizumab Injection for Diabetic Macular Edema

Diagnosis and treatment of diabetic retinopathy. Blake Cooper MD Ophthalmologist Vitreoretinal Surgeon Retina Associates Kansas City

Evaluation of Changes of Macular Thickness in Diabetic Retinopathy after Cataract Surgery

Fundus Fluorescein Angiography in Diabetic Retinopathy: Correlation of Angiographic Findings to the Clinical Maculopathy Abstract: Purpose:

Vitrectomy for Diabetic Retinopathy The current role of pars plana vitrectomy for diabetic macular edema and proliferative diabetic retinopathy.

Optical Coherence Tomography in Diabetic Retinopathy. Mrs Samantha Mann Consultant Ophthalmologist Clinical Lead of SEL-DESP

Clinical Case Presentation. Branch Retinal Vein Occlusion. Sarita M. Registered Nurse Whangarei Base Hospital

Eyes on Diabetics: How to Avoid Blindness in Diabetic Patient

VMA at the macula resulting in VMT

JMSCR Vol 06 Issue 12 Page December 2018

Treatment for Central-Involved Diabetic Macular Edema in Eyes with Very Good Visual Acuity

Novel imaging techniques for diabetic macular edema

INTRODUCTION. Trans Am Ophthalmol Soc 2010;108:62-76

R&M Solutions

Vitrectomy Combined with Phacoemulsification and Intraocular Lens Implantation for Diabetic Macular Edema

Optical Coherence Tomography (OCT) in Uveitis Piergiorgio Neri, BMedSc, MD, PhD Head Ocular Immunology Unit

Marcus Gonzales, OD, FAAO Cedar Springs Eye Clinic

Intravitreal Triamcinolone Acetonide for Macular Edema in HLA-B27 Negative Ankylosing Spondylitis

EFFICACY OF INTRAVITREAL TRIAMCINOLONE ACETONIDE FOR THE TREATMENT OF DIABETIC MACULAR EDEMA

Subclinical Diabetic Macular Edema Study

RETINAL THICKENING MAY BE PRESENT IN A NUMBER. B-scan Ultrasonography for the Detection of Macular Thickening METHODS

DIABETIC RETINOPATHY (DR) PREFERRED PRACTICE PATTERNS (PPP) Philippines 2016


Patterns of Macular Edema in Uveitis as Diagnosed by Optical Coherence Tomography in Tertiary Eye Center

Diabetic Management beyond traditional risk factors and LDL-C control: Can we improve macro and microvascular risks?

Mariam Raouf Fadel M.B., B.Ch. M.Sc., Cairo University. A thesis. Submitted by. For partial fulfillment of. MD Degree in Ophthalmology

Use of Scanning Laser Ophthalmoscope Microperimetry in Clinically Significant Macular Edema in Type 2 Diabetes Mellitus

Diabetic macular edema and its association to systemic risk factors in an urban north Indian population.

Diabetic Retinopathy and Peripapillary Retinal Thickness

Diabetic retinopathy accounts for much of the visual impairment

THE NATURAL HISTORY OF TRACTIONAL CYSTOID MACULAR EDEMA

Study of 189 Cases of Diabetic Retinopathy at CMC Larkana

The effect of intravitreal bevacizumab in a rare case of retinal dystrophy with secondary cystoid macular edema

Diabetic retinopathy (DR) progressively

Perspectives on Screening for Diabetic Retinopathy. Dr. Dan Samaha, Optometrist, MSc Clinical Lecturer School of Optometry, Université de Montréal

Classification of diabetic retinopathy and diabetic macular edema

Fundus Autoflu ores cence Findings Pre and Post Intravitreal Bevacizumab Injection in Patients with Diabetic Macular Edema

CLINICAL SCIENCES. Optical Coherence Tomography Findings in Myopic Traction Maculopathy

OCCLUSIVE VASCULAR DISORDERS OF THE RETINA

Intravitreal versus Posterior Subtenon Injection of Triamcinolone Acetonide for Diabetic Macular Edema

Serious Eye diseases, New treatments. Mr. M. Usman Saeed MBBS, FRCS, FRCOphth Consultant Ophthalmologist

PREDICTIVE FACTORS OF VISUAL OUTCOME FOR VITREOMACULAR TRACTION SYNDROME AFTER VITRECTOMY

Diabetic Macular Edema Treatment in the 21st Century

Prevalence and causes of macular edema and its correlation: an observational study

Intravitreal bevacizumab for pediatric exudative retinal diseases

POSTERIOR SUBTENON INJECTION OF TRIAMCINALONE ACETONIDE FOR CYSTOID DIABETIC MACULAR EDEMA

UNDERTAKING MACULAR DISORDERS STUDIED WITH OPTICAL COHERENCE TOMOGRAPHY. taking full responsibility for the originality of the material submitted &

Diabetic Retinopathy Clinical Research Network

Case report 12/10/2014. Delphine Lam ; Dr Mayer Srour Service d ophtalmologie Professeur E.Souied Université Paris Est

Audit of Macular Hole Surgery, Visual Outcome Prediction on OCT Appearance of Macular Hole

ZEISS AngioPlex OCT Angiography. Clinical Case Reports

International Journal of Health Sciences and Research ISSN:

IN NICU OCT UTILIZES A CONCEPT KNOWN AS INTERFEROMETRY APPLICATIONS FOR OCT THE PRIMARY USE IN THE EYE - RETINA

In its initial report, the Early Treatment Diabetic Retinopathy. A Severity Scale for Diabetic Macular Edema Developed from ETDRS Data

Diabetic Retinopathy WHAT IS DIABETIC RETINOPATHY? WHAT CAUSES DIABETIC RETINOPATHY? WHAT ARE THE STAGES OF DIABETIC RETINOPATHY?

Technologies and Methods for Visualizing the Retina

Optical Coherence Tomography Fast versus Regular Macular Thickness Mapping in Diabetic Retinopathy

Kyungmin Lee, Heeyoung Chung, Youngsuk Park, Joonhong Sohn. HanGil Eye Hospital, Incheon, Korea

DIABETIC RETINOPATHY

Diabetic Retinopathy Clinical Research Network

Intravitreal Ranibizumab or Triamcinolone Acetonide in Combination with Laser Photocoagulation for Diabetic Macular Edema

DOME SHAPED MACULOPATHY. Ιωάννης Ν. Βαγγελόπουλος Χειρ. Οφθαλμίατρος - Βόλος

Diabetic Retinopathy Clinical Research Network

Transcription:

Original Research Article Study of clinical significance of optical coherence tomography in diagnosis & management of diabetic macular edema Neha Kantilal Desai 1,*, Somesh Vedprakash Aggarwal 2, Sonali Satish Shah 3, Puja Shubham Negi 4 1 Assistant Professor, 2 Professor, 3 Associate Professor, 4 Tutor Dept. of Ophthalmology, B.J Medical College, Ahmedabad, Gujarat *Corresponding Author E-mail: dr.neha_desai@yahoo.com Abstract Background: 26 million people were estimated to be affected by diabetes in 2010 across the globe. Diabetic macular edema (DME) is the most important cause of visual impairment due to diabetic retinopathy. Optical Coherence Tomography (OCT) is a non-invasive modality which produces cross-sectional or three-dimensional, high-resolution images of the retinal layers and quantitative assessment of retinal thickness Aim of study was to study the incidence of different patterns of diabetic macular edema on Optical coherence tomography (OCT), to decide treatment & follow-up protocol. Material & Methods: 200 eyes of 167 patients attending the M & J Institute of Ophthalmology and having diabetic macular edema were enrolled in this study. Base line examination like best corrected visual acuity, anterior segment examination, indirect ophthalmoscopy, slit lamp biomicroscopy, OCT and fundus fluorescein angiography were done in all patients. The patients will be classified according to type of macular edema on OCT. Follow up visits will be scheduled one week, one month post procedure and every two monthly thereafter. Results: In this non-randomized, prospective study, 200 eyes of 167 patients with diabetic macular edema were enrolled. Out of 167 patients 33 (19.7%) patients were having DME in both eyes. Single type of edema was present in 122 (61%) eyes, combination of two types of edema in 56 (28%) eyes & combination of three types of edema in 22 (11%) eyes. Grid laser treatment was given in 72 (36%) eyes. Intravitreal triamcinolone injection was given in 110 (55%) eyes. Parsplana vitrectomy was done in 18 (9%) eyes. Discussion: Diabetic macular edema is the most important cause of visual impairment in patients with diabetes. OCT is a noninvasive and reproducible tool for obtaining high resolution, cross-sectional images of the retina. In our study spongy edema was most common type found (36%), followed by cystoid edema (14%), serous detachment (7%) & vitreomacular traction in 2%. OCT provides a better anatomical description of CSME for deciding treatment protocols. Conclusion: Identifying the structural changes in eyes with DME using OCT may allow more effective management of these patients. Keywords: Diabetes mellitus, Macular edema, Optical coherence tomography Quick Response Code: Access this article online Website: www.innovativepublication.com DOI: 10.5958/2395-1451.2016.00003.2 Introduction In 2010, there were 26 million people who had diabetes & prevalence of diabetes is projected to increase significantly across the globe(1). Diabetic macular edema is the most common etiology of visual loss due to diabetic retinopathy. Diabetic macular edema may occur in either type 1 or type 2 diabetes but it is more common in type 2. The development of diabetic macular edema is associated with longer duration of disease, poor glycemic control & conversion to insulin therapy for type 2 diabetics(2). coherence tomography (OCT) has revolutionized the documentation & quantification of diabetic macular edema. Optical coherence tomography (OCT) is a noninvasive modality which produces cross-sectional or three-dimensional, high-resolution images of the retinal layers and quantitative assessment of retinal thickness and other features of macular edema(3). OCT is based on a technique called low-coherence interferometry, which uses multiple axial scans to produce a retinal image(4). Due to the fast scanning process, it allows a raster scanning providing data from all locations of the retina. OCT is very precise & delineates each layer of the retina with an axial resolution of less than 10micron(5). Advantages of OCT include non-contact, non-invasive, fine detail with which retina is image & can be repeated at various visits with extreme accuracy. In our study we have included 200 eyes of 167 patients with diabetic macular edema & we have studied different patterns of diabetic macular edema on OCT & its usefulness in management. Indian Journal of Clinical and Experimental Ophthalmology, January-March,2016;2(1): 76-80 76

Aims of Study 1. To study the incidence of different patterns of diabetic macular edema on optical coherence tomography (OCT) 2. To decide the treatment protocol on basis of type of diabetic macular edema on OCT 3. To assess the effect of different treatment modalities on follow-up Material & Methods 200 eyes of 167 patients attending the OPD at M & J Institute Of Ophthalmology and having Diabetic macular edema were enrolled in this study. For our study inclusion & exclusion criteria were as follow: Inclusion criteria were: 1. Patient of Diabetes Mellitus Type 2 2. Age >40 years 3. Diabetic macular Edema with any level of Diabetic retinopathy. Following patients were excluded from this study 1. Presence of any other posterior segment pathology affecting visual acuity. 2. Presence of any anterior segment pathology. 3. Patients with advanced cataractous changes, complicated pseudophakia and corneal opacities making fundus examination difficult. 4. Patients with previous history of any form of treatment taken for diabetic retinopathy. 5. Patients who found to have macular ischemia after doing FFA. 6. Pregnant, immunocompromised, known HIV and HbsAg positive patients were excluded. Written informed consent was taken before recruiting the patients for the study. Base line examination like best corrected visual acuity, anterior segment examination, indirect ophthalmoscopy, slit lamp bio microscopy, OCT and Fundus fluorescein angiography were done in all patients. Before doing FFA, routine blood investigations like FBS, PPBS, blood urea, serum creatinine & urine sugar were done The patients will be classified according to type of macular edema on Oct. 1 Spongy Edema (fig. 1) 2 Cystoid Edema (fig. 2) 3 Serous retinal detachment (fig. 3) 4 Taut posterior hyaloid membrane (fig. 4) 5 Foveal tractional retinal detachment (fig. 5) Fig. 1: Spongy Edema Fig. 2: Cystoid Edema Fig. 3: Serous retinal detachment Fig. 4: Taut posterior hyaloid membrane Indian Journal of Clinical and Experimental Ophthalmology, January-March,2016;2(1): 76-80 77

Table 3: Combination of two types of edema on OCT Type of Edema Cystoid + Spongy 36 Spongy + Serous 6 Cystoid + Serous 6 Spongy + TPH 4 Spongy + VMT 2 Cystoid + VMT 2 Total 56 Fig. 5: Foveal tractional retinal detachment Patients with diffuse macular edema were subjected to grid laser photocoagulation. Patients with serous retinal detachment and cystoid macular edema will be given intravitreal triamcinolone injection. Patients with taut posterior hyaloid and vitreomacular traction syndrome will be subjected to parsplana vitrectomy. Follow up visits will be scheduled one week, one month post procedure and every two monthly thereafter. Best Corrected Visual acuity, IOP measurement, cataract assessment, indirect ophthalmoscopy, slit lamp bio microscopy, optical coherence tomography will be done at each visit. Retreatment assessment will be done every 3 months and patient will be treated as required. Results In this non-randomized, prospective study, 200 eyes of 167 patients with diabetic macular edema were included. Out of 167 patients 33 (19.7%) patients were having DME in both eyes. Table 1: Range of visual acuity Visual Acuity Percentage 6/6 to 6/18 36 18% 6/24 to 6/60 96 48% <6/60 68 34% Table 2: Types of single edema on OCT Type of edema Spongy 72 Cystoid 28 Serous Detachment 14 Taut posterior hyaloid 4 Tractional RD 4 Total 122 Single type of edema was present in 122 (61%) eyes, combination of two types of edema in 56 (28%) eyes & combination of three types of edema in 22 (11%) eyes. Table 4: Combination of three types of edema on OCT Type of edema Cystoid + Spongy + Serous 20 Cystoid + Serous + tphm 2 Total 22 Table 5: Central foveal thickness on OCT Central Foveal Percentage Thickness 250-350 114 57% 350-450 50 25% 450-600 22 11% >600 14 7% Grid laser treatment was given in 72 (36%) eyes. Intravitreal triamcinolone was given in 110 (55%) eyes. Parsplana vitrectomy was done in 18 (9%) eyes. Table 6: Improvement in visual acuity at the end of 1 year Visual Acuity Percentage 6/6 to 6/18 96 48% 6/24 to 6/60 76 38% <6/60 28 14% Table 7: Reduction in central foveal thickness at the end of 1 year Central Foveal Percentage Thickness 250-350 152 76% 350-450 36 18% 450-600 10 5% >600 2 1% The findings on fundus fluorescence angiography parallel those of visual acuity 16% of eyes treated with intravitreal triamcinolone injections had intraocular pressure >21 mm Hg and were treated topical antiglaucoma medication. 8% of eyes had rapid progression of cataract after intravitreal triamcinolone injections. There were no other complications like vitritis, vitreous hemorrhage, retinal detachment and endophthalmitis in Indian Journal of Clinical and Experimental Ophthalmology, January-March,2016;2(1): 76-80 78

patients treated with intravitreal triamcinolone injections. Discussion Diabetic retinopathy is the sixth leading cause of blindness in the world. Diabetic macular edema remains the most frequent cause of vision loss among the diabetic population and is particularly prevalent among Insulin dependent type 2 diabetics. Macular edema is clinically detected by slit-lamp biomicroscopy. The ETDRS (Early Treatment Diabetic Retinopathy Study) classified macular edema by its severity. It was defined as Clinically Significant Macular Edema (CSME) if any of the following features were present: 1) thickening of the retina at or within 500 micron of the center of macula 2) Hard exudates at or within 500 micron of the center of macula if associated with thickening of the adjacent retina. 3) A zone of retinal thickening one disc area or larger any part of which is within one disc diameter of the center of the macula(6). The physiologic aspect of DME can be assessed by fluorescein angiography, that is a kind of functional evaluation, the anatomical features of DME such as extent of thickening, the retinal layers involved and associated aspects can be described with OCT offering a structural and quantitative analysis of DME. OCT is a non-invasive, rapid and repeatable tool for obtaining high resolution cross-sectional images of the retina. In our study we have found five patterns of diabetic macular edema. In our study spongy edema was most common type found (36%), followed by cystoid edema (14%), serous detachment (7%) & vitreomacular traction in 2%. In the Alkuraya H et al study (1995), the spongy edema was the most common (45.4%), followed by the Cystoid edema (29.0%), serous retinal detachment (21.8%) and vitreofoveal traction (3.6%) patterns(7). In a study done by Otani T et al (1999), Spongy edema was the most common pattern (found in 88% of the patient)(8). Yang et al have suggested that the OCT is more sensitive than a clinical examination in assessing diabetic macular edema and is a better for documenting changes in macular thickening. Spongy macular edema was seen in 58% of eyes without CSME in that series(9). Schaudig et al also had similar observations who & also showed a significant increase in macular thickening in diabetic patients without diabetic retinopathy compared to non-diabetic patients(10). Ozdek et al had found spongy retinal thickening in 66%, Cystoid macular edema in 16% and serous retinal detachment in 10% of eyes with diabetic macular edema(11). Kim et al have reported spongy retinal thickening in 97%, Cystoid macular edema in 55%, Serous retinal detachment in 7%, VMT in 13% of eyes with diabetic macular edema(12). As macular ischemia can be a cause of visual loss in patients with diabetic macular edema, the present study excluded this group of patients during the analysis. 18% eyes have visual acuity better than 6/18, 48% have 6/24 to 6/60 & 34% had visual acuity less than 6/60. Alkuraya et al had reported that there was a positive correlation between the type of macular edema on OCT and best corrected visual acuity. Patients with CME and VMT had worse vision. Most of the other series had reported that the best corrected visual acuity correlated linearly with central foveal thickness. It is also found that the central foveal thickness increases with the different types of OCT presentations, being least for spongy thickening, moderate for CME/SRF and highest for VMT and thus visual loss correlate with these changes. With the advent of newer treatment modalities such as intravitreal anti-vascular endothelial growth factor injection (anti-vegf) intravitreal triamcinolone injection, posterior subtenon injection of triamcinolone and vitrectomy for diabetic macular edema, the laser therapy for diabetic macular edema is better reserved for selected groups of patients. OCT provides a better anatomical description of diabetic macular edema for identification of the medically and surgically treatable groups. Conclusion Optical coherence tomography (OCT) is a newer & noninvasive tool to measure retinal thickness and other aspects associated with diabetic macular edema. Identifying the structural changes in eyes with DME using OCT may allow more effective management of these patients. In our study we have found five patterns of diabetic macular edema. In our study spongy edema was most common type found (36%), followed by cystoid edema (14%), serous detachment (7%) & vitreomacular traction in 2%. In our study, Patients with only spongy macular thickening on OCT responded better to conventional laser treatment. Patients with cystoid macular edema/serous retinal detachment responded best to IVTA/PST with or without focal laser and patients with ERM/VMT responded best with vitrectomy. Conflicts of Interest: None Source of Support: Nil References 1. Centers for Disease Control and Prevention. Diabetes in the UnitedStates.www.cdc.gov/diabetes/news/docs/diabetesmon th.htm. Accessed January 12, 2015. 2. American Academy of ophthalmology Retina Panel: Preferred practice pattern guidelines. Diabetic retinopathy. San Francisco, American academy of ophthalmology, 2008. 3. Hee MR et al, 1998; Otani T et al, 1999; Yamamoto S et al, 2001;Buabbud JC et al, 2010. 4. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181. Indian Journal of Clinical and Experimental Ophthalmology, January-March,2016;2(1): 76-80 79

5. Gabriele ML, Wollstein G, Ishikawa H, et al. Optical coherence tomography: history, current status & laboratory work. Invest Ophthalmol Vis Sci.2011;14:2425-2436. 6. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early treatment diabetic retinopathy study research group. Ophthalmology.1991;98(5 suppl):766-785. 7. Alkuraya H, Kangave D, Abu El-Asra AM. The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema. Int Ophthalmol 2005;26(3):93-99. 8. Otani T, Kishi S, Maruyama Y. Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999;127:688-693. 9. Quantitative Assessment of Retinal Thickness in Diabetics with or without CSME using OCT, Yang CS, Cheng CY; Acta Ophthalmol Scand 2001;79(3):266-70. 10. Optical coherence tomography for retinal thickness measurement in diabetic patients without clinically significant macular edema; Schaudig et al;ophthal Surg Laser 2000;31(3):182-6. 11. Optical Coherence Tomographic Assessment of Diabetic Macular Edema-Comparison with Fluorescein Angiographic and Clinical Findings; Sengui C Ozdek, Alper Erdinc, Gokhan Gurelik; Ophthalmologica 2005,219(2):86-92. 12. Optical Coherence tomographic patterns of diabetic macular edema; Kim BY et al, Am J Ophthal, 2006;142(3):405-12. Indian Journal of Clinical and Experimental Ophthalmology, January-March,2016;2(1): 76-80 80